Clinical trial
En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor-A Multi-center, Prospective, Randomized, Controlled Study.
NCT06120426 is registered in ClinicalTrials.gov with Shanghai Changzheng Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor-A Multi-center, Prospective, Randomized, Controlled Study.
- Lead sponsor
- Shanghai Changzheng Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 1, 2023
- Completion date
- July 1, 2027
- Enrollment
- 182 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
malignant bone tumor, radiotherapy, spinal metastases, spinal tumor, surgery